C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease

C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is characterised by accelerated lipid deposition, aberrant inflammation, and excessive extracellular matrix production in the liver. Short of effective intervention, NAFLD can progress to cirrhosis and hepatocellular carcinoma. In...

Full description

Bibliographic Details
Main Authors: Zhiwen Fan, Xinyue Sun, Xuelian Chen, Huimin Liu, Xiulian Miao, Yan Guo, Yong Xu, Jie Li, Xiaoping Zou, Zilong Li
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:JHEP Reports
Subjects:
Non-alcoholic fatty liver disease
Hepatocytes
Transcriptional regulation
Chemokine
Inflammation
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555923001362

Internet

http://www.sciencedirect.com/science/article/pii/S2589555923001362

Similar Items